Somatoform disorders in the family doctor's practice

Somatoform disorders – psychogenic diseases are characterized by pathological physical symptoms that resemble somatic illness. Thus, any organic manifestations, which can be attributed to known diseases are not detected, but there are non-specific functional impairments. Somatoform disorders include...

Full description

Saved in:
Bibliographic Details
Main Authors: Prykhodko V., Mikropulo I., Oleinik M., Kononenko E., Moreva D., Gogol O., Kashkovskiy D., Lisnyak O., Lisnyak A.
Format: Article
Language:English
Published: Dnipro State Medical University 2013-10-01
Series:Medičnì Perspektivi
Subjects:
Online Access:http://medpers.dsma.dp.ua/issues/2013/N3/15-24.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846095632903700480
author Prykhodko V.
Mikropulo I.
Oleinik M.
Kononenko E.
Moreva D.
Gogol O.
Kashkovskiy D.
Lisnyak O.
Lisnyak A.
author_facet Prykhodko V.
Mikropulo I.
Oleinik M.
Kononenko E.
Moreva D.
Gogol O.
Kashkovskiy D.
Lisnyak O.
Lisnyak A.
author_sort Prykhodko V.
collection DOAJ
description Somatoform disorders – psychogenic diseases are characterized by pathological physical symptoms that resemble somatic illness. Thus, any organic manifestations, which can be attributed to known diseases are not detected, but there are non-specific functional impairments. Somatoform disorders include somatization disorder, undifferentiated somatoform disorder, hypocho¬n¬driacal disorder, somatoform dysfunction of the autonomic nervous system and stable somatoform pain disorder. The first part of the article reviewes features of the clinical manifestations of somatization disorder and undifferentiated somatoform disorder. Role of non-benzodiazepine tranquilizers (ADAPTOL) and metabolic drugs (VASONAT) in the treatment of patients with somatoform disorders is discussed. In review article data of neurologists and cardiologists on the effectiveness of anxiolytic drug ADAPTOL and metabolic drug VASONAT in different clinical groups of patients (coronary artery disease, chronic ischemia of the brain), which can significantly improve quality of life, increase exercise tolerance, improve cognitive function and correct mental and emotional disorders are presented.
format Article
id doaj-art-15ef9d1c19304b1db27e2af7f9a03d6e
institution Kabale University
issn 2307-0404
2307-0404
language English
publishDate 2013-10-01
publisher Dnipro State Medical University
record_format Article
series Medičnì Perspektivi
spelling doaj-art-15ef9d1c19304b1db27e2af7f9a03d6e2025-01-02T09:46:06ZengDnipro State Medical UniversityMedičnì Perspektivi2307-04042307-04042013-10-011831524Somatoform disorders in the family doctor's practicePrykhodko V.0Mikropulo I.1Oleinik M.2Kononenko E.3Moreva D.4Gogol O.5Kashkovskiy D.6Lisnyak O.7Lisnyak A. 8National medical academy of postgraduate training named after Shupik P.L.National medical academy of postgraduate training named after Shupik P.L.National medical academy of postgraduate training named after Shupik P.L.National medical academy of postgraduate training named after Shupik P.L.National medical academy of postgraduate training named after Shupik P.L.National medical academy of postgraduate training named after Shupik P.L.National medical academy of postgraduate training named after Shupik P.L.Kyiv City Clinical Hospital for disabled war veteransKyiv City Clinical Hospital for disabled war veteransSomatoform disorders – psychogenic diseases are characterized by pathological physical symptoms that resemble somatic illness. Thus, any organic manifestations, which can be attributed to known diseases are not detected, but there are non-specific functional impairments. Somatoform disorders include somatization disorder, undifferentiated somatoform disorder, hypocho¬n¬driacal disorder, somatoform dysfunction of the autonomic nervous system and stable somatoform pain disorder. The first part of the article reviewes features of the clinical manifestations of somatization disorder and undifferentiated somatoform disorder. Role of non-benzodiazepine tranquilizers (ADAPTOL) and metabolic drugs (VASONAT) in the treatment of patients with somatoform disorders is discussed. In review article data of neurologists and cardiologists on the effectiveness of anxiolytic drug ADAPTOL and metabolic drug VASONAT in different clinical groups of patients (coronary artery disease, chronic ischemia of the brain), which can significantly improve quality of life, increase exercise tolerance, improve cognitive function and correct mental and emotional disorders are presented.http://medpers.dsma.dp.ua/issues/2013/N3/15-24.pdfsomatoformic disordersvegetative dysfunctionmethabolic therapyanxiolytics
spellingShingle Prykhodko V.
Mikropulo I.
Oleinik M.
Kononenko E.
Moreva D.
Gogol O.
Kashkovskiy D.
Lisnyak O.
Lisnyak A.
Somatoform disorders in the family doctor's practice
Medičnì Perspektivi
somatoformic disorders
vegetative dysfunction
methabolic therapy
anxiolytics
title Somatoform disorders in the family doctor's practice
title_full Somatoform disorders in the family doctor's practice
title_fullStr Somatoform disorders in the family doctor's practice
title_full_unstemmed Somatoform disorders in the family doctor's practice
title_short Somatoform disorders in the family doctor's practice
title_sort somatoform disorders in the family doctor s practice
topic somatoformic disorders
vegetative dysfunction
methabolic therapy
anxiolytics
url http://medpers.dsma.dp.ua/issues/2013/N3/15-24.pdf
work_keys_str_mv AT prykhodkov somatoformdisordersinthefamilydoctorspractice
AT mikropuloi somatoformdisordersinthefamilydoctorspractice
AT oleinikm somatoformdisordersinthefamilydoctorspractice
AT kononenkoe somatoformdisordersinthefamilydoctorspractice
AT morevad somatoformdisordersinthefamilydoctorspractice
AT gogolo somatoformdisordersinthefamilydoctorspractice
AT kashkovskiyd somatoformdisordersinthefamilydoctorspractice
AT lisnyako somatoformdisordersinthefamilydoctorspractice
AT lisnyaka somatoformdisordersinthefamilydoctorspractice